180 related articles for article (PubMed ID: 37432392)
1. IL-6 selectively suppresses cDC1 specification via C/EBPβ.
Kim S; Chen J; Jo S; Ou F; Ferris ST; Liu TT; Ohara RA; Anderson DA; Wu R; Chen MY; Gillanders WE; Gillanders WE; Murphy TL; Murphy KM
J Exp Med; 2023 Oct; 220(10):. PubMed ID: 37432392
[TBL] [Abstract][Full Text] [Related]
2. Ablation of cDC2 development by triple mutations within the Zeb2 enhancer.
Liu TT; Kim S; Desai P; Kim DH; Huang X; Ferris ST; Wu R; Ou F; Egawa T; Van Dyken SJ; Diamond MS; Johnson PF; Kubo M; Murphy TL; Murphy KM
Nature; 2022 Jul; 607(7917):142-148. PubMed ID: 35732734
[TBL] [Abstract][Full Text] [Related]
3. An Nfil3-Zeb2-Id2 pathway imposes Irf8 enhancer switching during cDC1 development.
Bagadia P; Huang X; Liu TT; Durai V; Grajales-Reyes GE; Nitschké M; Modrusan Z; Granja JM; Satpathy AT; Briseño CG; Gargaro M; Iwata A; Kim S; Chang HY; Shaw AS; Murphy TL; Murphy KM
Nat Immunol; 2019 Sep; 20(9):1174-1185. PubMed ID: 31406377
[TBL] [Abstract][Full Text] [Related]
4. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
Durai V; Bagadia P; Granja JM; Satpathy AT; Kulkarni DH; Davidson JT; Wu R; Patel SJ; Iwata A; Liu TT; Huang X; Briseño CG; Grajales-Reyes GE; Wöhner M; Tagoh H; Kee BL; Newberry RD; Busslinger M; Chang HY; Murphy TL; Murphy KM
Nat Immunol; 2019 Sep; 20(9):1161-1173. PubMed ID: 31406378
[TBL] [Abstract][Full Text] [Related]
5. Importance of EMT Factor ZEB1 in cDC1 "MutuDC Line" Mediated Induction of Th1 Immune Response.
Smita S; Ahad A; Ghosh A; Biswas VK; Koga MM; Gupta B; Acha-Orbea H; Raghav SK
Front Immunol; 2018; 9():2604. PubMed ID: 30483264
[TBL] [Abstract][Full Text] [Related]
6. Differential Activation of Splenic cDC1 and cDC2 Cell Subsets following Poxvirus Infection of BALB/c and C57BL/6 Mice.
Szulc-Dąbrowska L; Biernacka Z; Koper M; Struzik J; Gieryńska M; Schollenberger A; Lasocka I; Toka FN
Cells; 2023 Dec; 13(1):. PubMed ID: 38201217
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor C/EBPβ orchestrates dendritic cell maturation and functionality under homeostatic and malignant conditions.
Scholz F; Grau M; Menzel L; Graband A; Zapukhlyak M; Leutz A; Janz M; Lenz G; Rehm A; Höpken UE
Proc Natl Acad Sci U S A; 2020 Oct; 117(42):26328-26339. PubMed ID: 33020261
[TBL] [Abstract][Full Text] [Related]
8. XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors.
Heger L; Hatscher L; Liang C; Lehmann CHK; Amon L; Lühr JJ; Kaszubowski T; Nzirorera R; Schaft N; Dörrie J; Irrgang P; Tenbusch M; Kunz M; Socher E; Autenrieth SE; Purbojo A; Sirbu H; Hartmann A; Alexiou C; Cesnjevar R; Dudziak D
Proc Natl Acad Sci U S A; 2023 Aug; 120(33):e2300343120. PubMed ID: 37566635
[TBL] [Abstract][Full Text] [Related]
9. Very early-life exposure to microbiota-induced TNF drives the maturation of neonatal pre-cDC1.
Köhler A; Delbauve S; Smout J; Torres D; Flamand V
Gut; 2021 Mar; 70(3):511-521. PubMed ID: 32546472
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Type 1 Porcine Reproductive and Respiratory Syndrome Virus With
Li Y; Mateu E
Front Immunol; 2021; 12():674185. PubMed ID: 34177915
[TBL] [Abstract][Full Text] [Related]
11. Conventional Type 1 Dendritic Cells in Intestinal Immune Homeostasis.
Sasaki I; Kato T; Hemmi H; Fukuda-Ohta Y; Wakaki-Nishiyama N; Yamamoto A; Kaisho T
Front Immunol; 2022; 13():857954. PubMed ID: 35693801
[TBL] [Abstract][Full Text] [Related]
12. GM-CSF, Flt3-L and IL-4 affect viability and function of conventional dendritic cell types 1 and 2.
Lellahi SM; Azeem W; Hua Y; Gabriel B; Paulsen Rye K; Reikvam H; Kalland KH
Front Immunol; 2022; 13():1058963. PubMed ID: 36713392
[TBL] [Abstract][Full Text] [Related]
13. C/EBPβ is a transcriptional key regulator of IL-36α in murine macrophages.
Nerlich A; Ruangkiattikul N; Laarmann K; Janze N; Dittrich-Breiholz O; Kracht M; Goethe R
Biochim Biophys Acta; 2015 Aug; 1849(8):966-78. PubMed ID: 26066982
[TBL] [Abstract][Full Text] [Related]
14. γ-Tocotrienol inhibits lipopolysaccharide-induced interlukin-6 and granulocyte colony-stimulating factor by suppressing C/EBPβ and NF-κB in macrophages.
Wang Y; Jiang Q
J Nutr Biochem; 2013 Jun; 24(6):1146-52. PubMed ID: 23246159
[TBL] [Abstract][Full Text] [Related]
15. STAT3 Inhibits Autocrine IFN Signaling in Type I Conventional Dendritic Cells.
Chrisikos TT; Zhou Y; Kahn LM; Patel B; Denne NL; Brooks A; Shen L; Wang J; Watowich SS
J Immunol; 2022 Oct; 209(7):1286-1299. PubMed ID: 36038291
[TBL] [Abstract][Full Text] [Related]
16. Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance.
Meyer MA; Baer JM; Knolhoff BL; Nywening TM; Panni RZ; Su X; Weilbaecher KN; Hawkins WG; Ma C; Fields RC; Linehan DC; Challen GA; Faccio R; Aft RL; DeNardo DG
Nat Commun; 2018 Mar; 9(1):1250. PubMed ID: 29593283
[TBL] [Abstract][Full Text] [Related]
17. The Conventional Dendritic Cell 1 Subset Primes CD8+ T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain.
Bowman-Kirigin JA; Desai R; Saunders BT; Wang AZ; Schaettler MO; Liu CJ; Livingstone AJ; Kobayashi DK; Durai V; Kretzer NM; Zipfel GJ; Leuthardt EC; Osbun JW; Chicoine MR; Kim AH; Murphy KM; Johanns TM; Zinselmeyer BH; Dunn GP
Cancer Immunol Res; 2023 Jan; 11(1):20-37. PubMed ID: 36409838
[TBL] [Abstract][Full Text] [Related]
18. C/EBPbeta mediates synergistic upregulation of gene expression by interferon-gamma and tumor necrosis factor-alpha in bone marrow-derived mesenchymal stem cells.
Xu G; Zhang Y; Zhang L; Roberts AI; Shi Y
Stem Cells; 2009 Apr; 27(4):942-8. PubMed ID: 19353522
[TBL] [Abstract][Full Text] [Related]
19.
Liu TT; Ou F; Belk JA; Bagadia P; Anderson DA; Durai V; Yao W; Satpathy AT; Murphy TL; Murphy KM
Genes Dev; 2023 Apr; 37(7-8):291-302. PubMed ID: 36990511
[TBL] [Abstract][Full Text] [Related]
20. IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer.
Hubert M; Gobbini E; Couillault C; Manh TV; Doffin AC; Berthet J; Rodriguez C; Ollion V; Kielbassa J; Sajous C; Treilleux I; Tredan O; Dubois B; Dalod M; Bendriss-Vermare N; Caux C; Valladeau-Guilemond J
Sci Immunol; 2020 Apr; 5(46):. PubMed ID: 32303573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
